Searched for
USFDA
Aurobindo Pharma arm Eugia Pharma's Telangana unit gets warning letter from USFDAAurobindo Pharma announced its subsidiary Eugia Pharma received a USFDA warning letter. This follows an inspection of their Telangana formu...- Independence Day 2026: India, which once couldn't make smallpox vaccine, has now crossed a pharma milestone the world can't ignore2026 Independence Day: India's pharmaceutical industry marks a historic milestone with a new drug approval. This achievement reflects decad...
- Dr Reddy's Laboratories launches generic Sugammadex injection in the United StatesDr Reddy's Laboratories has launched its generic Sugammadex injection in the United States. This new product reverses muscle relaxant effec...
- MOFSL stays bullish on Sun Pharma; sees 16% upside on innovation pipelineSun Pharma's June quarter results met analyst expectations, signaling future growth. The company is expanding its specialty and innovative ...
- Lupin launches generic Sugammadex injection in USLupin Limited announced the launch of its Sugammadex Injection in the United States. This follows approval from the US Food and Drug Admini...
- Gland Pharma gets USFDA nod for generic sugammadex injectionGland Pharma secured USFDA approval for its sugammadex injection generic version. This drug reverses muscle relaxant effects used during su...
- BDR Pharmaceuticals eyes controlling stake in Acme FormulationPAG acquired a controlling stake in Acme Formulation for $145 million (?1,054 crore) through its PAG Asia III buyout fund in 2021. Founder ...
- Alembic Pharma gets USFDA approval for generic chronic constipation treatment tabletsAlembic Pharmaceuticals announced USFDA approval for its generic prucalopride tablets. The company received final approval for strengths of...
- Domestic formulations, chronic therapies to drive Pharma Q1; US generics remain dragThe healthcare sector anticipates strong growth in domestic formulations and emerging markets. Companies with less US generics dependence w...
- Trump's Generic Drug Tariffs Explained: What it means for Indian pharma before the 200% stormTrump's generic drug tariffs plan provides Indian drugmakers a two-year duty-free window. This allows companies time to reassess manufactur...
- Glenmark sees innovative products driving 70% revenue in 5-6 years: CMD Glenn SaldanhaGlenmark anticipates innovative products will drive nearly seventy percent of its revenue. This strategic shift moves the company away from...
- Glenmark gets USFDA nod for expanded use of RYALTRIS nasal sprayGlenmark Pharmaceuticals announced US FDA approval for RYALTRIS nasal spray. This approval expands its use to children aged six to twelve y...
- Takeda Biopharmaceuticals gets DCGI nod for dengue vaccine QDENGATakeda Biopharmaceuticals India has received market authorization for its dengue vaccine QDENGA. This vaccine is now approved for individua...
- Alembic Pharma partner NATCO gets USFDA tentative nod for generic Olaparib tablets; US market size at USD 1.4 bnAlembic Pharmaceuticals and NATCO Pharma received tentative USFDA approval for generic Olaparib tablets. This approval is for a cancer drug...
- Stocks, gold and debt: Why ICICI Pru’s Dharmesh Kakkad favours a multi-asset strategy nowICICI Prudential's Dharmesh Kakkad advises investors against chasing the best-performing asset classes, arguing that a dynamic multi-asset ...
- Stocks in news: Hero MotoCorp, Canara Bank, Bharti Airtel, Indian Hotels, SBIIndian markets opened positively, with analysts suggesting a stock-specific strategy amidst consolidation. Hero MotoCorp sees a revival in ...
- Mankind Pharma joins hands with Denovo Sciences for AI-powered drug discoveryMankind Pharma has joined forces with Denovo Sciences to revolutionize drug discovery using artificial intelligence. This strategic partner...
- Alembic Pharmaceuticals gets USFDA nod for generic acne treatment gelAlembic Pharmaceuticals has secured final USFDA approval for its generic Dapsone gel, a topical treatment for acne vulgaris. This approval,...
- Alembic Pharma gets USFDA nod for generic influenza treatment drugAlembic Pharmaceuticals has secured USFDA approval for its generic oseltamivir phosphate oral suspension, a key treatment for influenza. Th...
- Lupin gets USFDA tentative approval for prostate cancer treatment drugIndian pharmaceutical giant Lupin Ltd has secured tentative approval from the US FDA for its generic enzalutamide tablets, a crucial treatm...
Load More
